353 related articles for article (PubMed ID: 28382372)
1. Mechanism of plasmin generation by S100A10.
Miller VA; Madureira PA; Kamaludin AA; Komar J; Sharma V; Sahni G; Thelwell C; Longstaff C; Waisman DM
Thromb Haemost; 2017 Jun; 117(6):1058-1071. PubMed ID: 28382372
[TBL] [Abstract][Full Text] [Related]
2. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
Kwon M; MacLeod TJ; Zhang Y; Waisman DM
Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
[TBL] [Abstract][Full Text] [Related]
3. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.
MacLeod TJ; Kwon M; Filipenko NR; Waisman DM
J Biol Chem; 2003 Jul; 278(28):25577-84. PubMed ID: 12730231
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
Lobov S; Croucher DR; Saunders DN; Ranson M
Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
[TBL] [Abstract][Full Text] [Related]
5. Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10.
Madureira PA; Bharadwaj AG; Bydoun M; Garant K; O'Connell P; Lee P; Waisman DM
Oncotarget; 2016 Jul; 7(30):47720-47737. PubMed ID: 27351226
[TBL] [Abstract][Full Text] [Related]
6. Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11.
He KL; Deora AB; Xiong H; Ling Q; Weksler BB; Niesvizky R; Hajjar KA
J Biol Chem; 2008 Jul; 283(28):19192-200. PubMed ID: 18434302
[TBL] [Abstract][Full Text] [Related]
7. Regulation of fibrinolysis by S100A10 in vivo.
Surette AP; Madureira PA; Phipps KD; Miller VA; Svenningsson P; Waisman DM
Blood; 2011 Sep; 118(11):3172-81. PubMed ID: 21768297
[TBL] [Abstract][Full Text] [Related]
8. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
Bakker AH; Nieuwenbroek NM; Verheijen JH
Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
[TBL] [Abstract][Full Text] [Related]
9. The Annexin A2/S100A10 Complex: The Mutualistic Symbiosis of Two Distinct Proteins.
Bharadwaj A; Kempster E; Waisman DM
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944495
[TBL] [Abstract][Full Text] [Related]
10. RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells.
Zhang L; Fogg DK; Waisman DM
J Biol Chem; 2004 Jan; 279(3):2053-62. PubMed ID: 14570893
[TBL] [Abstract][Full Text] [Related]
11. Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin.
de Vries C; Veerman H; Koornneef E; Pannekoek H
J Biol Chem; 1990 Aug; 265(23):13547-52. PubMed ID: 2143185
[TBL] [Abstract][Full Text] [Related]
12. On the contribution of S100A10 and annexin A2 to plasminogen activation and oncogenesis: an enduring ambiguity.
Bydoun M; Waisman DM
Future Oncol; 2014 Dec; 10(15):2469-79. PubMed ID: 25525855
[TBL] [Abstract][Full Text] [Related]
13. Herpesviruses enhance fibrin clot lysis.
Gershom ES; Vanden Hoek AL; Meixner SC; Sutherland MR; Pryzdial EL
Thromb Haemost; 2012 Apr; 107(4):760-8. PubMed ID: 22318336
[TBL] [Abstract][Full Text] [Related]
14. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
Sharma MC; Sharma M
Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
[TBL] [Abstract][Full Text] [Related]
15. Regulation of nonproteolytic active site formation in plasminogen.
Gladysheva IP; Sazonova IY; Houng A; Hedstrom L; Reed GL
Biochemistry; 2007 Jul; 46(30):8879-87. PubMed ID: 17616171
[TBL] [Abstract][Full Text] [Related]
16. The role of the annexin A2 heterotetramer in vascular fibrinolysis.
Madureira PA; Surette AP; Phipps KD; Taboski MA; Miller VA; Waisman DM
Blood; 2011 Nov; 118(18):4789-97. PubMed ID: 21908427
[TBL] [Abstract][Full Text] [Related]
17. The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis.
Madureira PA; O'Connell PA; Surette AP; Miller VA; Waisman DM
J Biomed Biotechnol; 2012; 2012():353687. PubMed ID: 23118506
[TBL] [Abstract][Full Text] [Related]
18. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation.
Kassam G; Le BH; Choi KS; Kang HM; Fitzpatrick SL; Louie P; Waisman DM
Biochemistry; 1998 Dec; 37(48):16958-66. PubMed ID: 9836589
[TBL] [Abstract][Full Text] [Related]
19. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
Sharma MR; Rothman V; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
[TBL] [Abstract][Full Text] [Related]
20. The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor.
Bharadwaj AG; Kempster E; Waisman DM
Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]